Market access and pricing consulting services for the healthcare industry

WHAT WE DELIVER

Actionable solutions and powerful insights

RJW&partners provides pricing and market access consulting services for the biotech and pharmaceutical sectors.

Our focus enables us to bring a unique perspective and deep expertise to our solutions. 

We understand the issues facing our clients and can work with you across all stages of the product lifecycle.

Asset 7.png

Pricing Strategy Development

It’s critical to have realistic assumptions of pricing potential and strategy at an early stage of a product’s development.

EVALUATING NEW OPPORTUNITIES_White.png

Evaluating New Opportunities

Payer perspectives and emerging trends are key inputs to pricing and market access opportunity assessments. 

VALUE PROPOSITION DEVELOPMENT_White.png

Value Proposition Development

It is essential to understand your product's anticipated usage and the unmet needs it may address to develop a compelling value story. 

EVIDENCE GAP ANALYSIS & PLANNING_White.p

Evidence Gap Analysis & Planning

Addressing the extensive clinical and economic evidence requirements for HTA assessments is key to market access and pricing success.

PAYER ENVIRONMENT ASSESSMENT_Navy.png

Payer Environment Assessment

Understanding the evolving payer environment is crucial to inform realistic short and long term pricing and market access goals.

PAYER NEGOTIATION TRAINING_White.png

Payer Negotiation Training

Payer facing affiliate teams need to understand and effectively communicate value messages, supporting evidence and objection handlers.